(No Gracias) Todos con ALLTRIALS http://t.co/7oQT01KDan #AllTrials #SegPAc
— Sano y salvo (@sanoysalvoblog) September 15, 2013
Review: Rivaroxaban causes less fatal bleeding, but does not reduce mortality, compared with VKAs http://t.co/usaXh6gXan #PtSafety
— Sano y salvo (@sanoysalvoblog) September 17, 2013
MT @Sefap_FAP Metanálisis vuelve a evidenciar mayor riesgo de tromboembolismo venoso para los ACO 3ª y 4ª gen http://t.co/ijZ7yUAi0w #SegPac
— Sano y salvo (@sanoysalvoblog) September 17, 2013
Quantification of harms in cancer screening trials: literature review | BMJ http://t.co/0GLO60TbQl #PtSafety
— Sano y salvo (@sanoysalvoblog) September 17, 2013
Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy | BMJ http://t.co/DKr4RIItyi #PtSafety
— Sano y salvo (@sanoysalvoblog) September 17, 2013
Antioxidantes: No disminuyen la mortalidad. Betacaroteno, Vit. E y altas dosis de Vit. A podrían aumentarla http://t.co/F1h5qBgqUr #SegPac
— Sano y salvo (@sanoysalvoblog) September 17, 2013
Ensuring the integrity of clinical practice guidelines: a tool for protecting patients http://t.co/Gyc1GCZeTR #PtSafety #ConflictOfInterest
— Sano y salvo (@sanoysalvoblog) September 17, 2013
(CMAJ) Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment:meta-analysis http://t.co/ccwcA9nIu0 #PtSafety
— Sano y salvo (@sanoysalvoblog) September 18, 2013
Measuring the Severity of Prescribing Errors: A Systematic Review http://t.co/NKvXZvCXeK #PtSafety
— Sano y salvo (@sanoysalvoblog) September 18, 2013
Tendon Injury and Fluoroquinolone Use: A Systematic Review http://t.co/REapeB3AqC #PtSafety
— Sano y salvo (@sanoysalvoblog) September 18, 2013
All trials registered. All results reported. http://t.co/AyBwicIevu #AllTrials #PtSafety
— Sano y salvo (@sanoysalvoblog) September 18, 2013
Alzheimer's drugs may harm people with mild memory issues http://t.co/dVTlQiyhOV
— Médicos Sin Marca (@MedicosSinMarca) September 17, 2013
MT @MedicosSinMarca Resultados desfavorables para nuevos medicamentos han sido ocultados http://t.co/Gsk0upZPdS #SegPac #AllTrials
— Sano y salvo (@sanoysalvoblog) September 18, 2013
(Drug Safety) Post-Approval Safety Issues with Innovative Drugs: A European Cohort Study http://t.co/79UWgMN4sa #PtSafety
— Sano y salvo (@sanoysalvoblog) September 19, 2013
Experiència pilot a Salou amb una eina que gestiona les mesures de seguretat dels pacients: http://t.co/i0AnmrncO1 #SegPac
— Sano y salvo (@sanoysalvoblog) September 19, 2013
(El Gerente De Mediado) Sobradamente... confiados http://t.co/0NJBZCvXu4 #SegPac
— Sano y salvo (@sanoysalvoblog) September 20, 2013
(BMJ) Friends, doctors, and tramadol: we might have a problem http://t.co/6sBjlCbUP3 #PtSafety
— Sano y salvo (@sanoysalvoblog) September 20, 2013
(BMJ) UK government is to reconsider claims of children who developed narcolepsy after vaccination http://t.co/63IMJI4AOz #PtSafety
— Sano y salvo (@sanoysalvoblog) September 20, 2013
Riesgo de confusión de las dosis de 25 mcg y 12 mcg de Durogesic Matrix pic.twitter.com/6NMCgrK0Qv vía @LukasMacia
— Sano y salvo (@sanoysalvoblog) September 20, 2013
RT @JesusmRedondo Riesgo de alteraciones severas de glucemia en pacientes que toman quinolonas http://t.co/PzMb9X5iuA #SegPac
— Sano y salvo (@sanoysalvoblog) September 20, 2013
(BMJ Qual Saf ) Suplemento monográfico de "Diagnostic Error in Medicine",octubre 2013 http://t.co/tHhSyqczYJ #SegPac #PtSafety
— Sano y salvo (@sanoysalvoblog) September 21, 2013
Planned home births carry significant risks, study shows http://t.co/t4eDhngWfp Article AJOG: http://t.co/2ZYgN4w6Nd #PtSafety
— Sano y salvo (@sanoysalvoblog) September 21, 2013
“@nytimeshealth: C.D.C. Report Finds 23,000 Deaths a Year From Antibiotic-Resistant Infections http://t.co/vckTRV7Uhu” #ptsafety
— Naomi Kaufman Price (@writeo) September 16, 2013
Ambulatory Misdiagnosis: Challenges and Opportunities https://t.co/fYKABhkr9t #PtSafety via @AEGRIS2
— Sano y salvo (@sanoysalvoblog) September 21, 2013
*El equipo que mantiene @sanoysalvoblog está compuesto por Cecilia Calvo Pita @cecilicp y Jesús Palacio Lapuente @je_pala.
Realiza la publicación de estas selecciones Txema Coll Benejam @txemacoll.
No hay comentarios:
Publicar un comentario